AnaptysBio, Inc. (ANAB)
48.10
+0.16
(+0.33%)
USD |
NASDAQ |
Oct 22, 16:00
48.10
0.00 (0.00%)
After-Hours: 20:00
AnaptysBio Gross Profit Margin (Quarterly) : 0.00% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00% |
| March 31, 2026 | 97.61% |
| December 31, 2025 | 99.44% |
| September 30, 2025 | 99.20% |
| June 30, 2025 | 97.30% |
| March 31, 2025 | 97.82% |
| December 31, 2024 | 98.61% |
| September 30, 2024 | 98.01% |
| June 30, 2024 | 94.58% |
| March 31, 2024 | 91.57% |
| December 31, 2023 | 93.29% |
| September 30, 2023 | 82.16% |
| June 30, 2023 | 83.03% |
| March 31, 2023 | 56.84% |
| December 31, 2022 | 91.10% |
| September 30, 2022 | 54.76% |
| June 30, 2022 | 53.04% |
| March 31, 2022 | 40.93% |
| December 31, 2021 | 0.00% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | |
| June 30, 2019 | 0.00% |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | 0.00% |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.00% |
| September 30, 2017 | |
| June 30, 2017 | 0.00% |
| March 31, 2017 | |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
| March 31, 2014 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | 98.50% |
| Amgen, Inc. | 72.08% |
| Anika Therapeutics, Inc. | 65.15% |
| BioCryst Pharmaceuticals, Inc. | 98.01% |
| Imunon, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | 69.74% |
| Return on Invested Capital | 79.47% |
| Return on Net Operating Assets | 475.6% |